Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, NK-cell

Explore clinical trials studying Lymphoma, NK-cell. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, NK-cell trial results

Completed

A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms

NCT01309789

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions